Re: Call for worldwide withdrawal of tiotropium Respimat mist inhaler
We share the concerns of Duncan Petty and Toby Hillman regarding the illustration of the Handihaler device. The authors did not see or approve the illustration as it was not included in the electronic proofs.
Competing interests:
All authors have completed the ICMJE uniform disclosure form at
www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and
declare: no support from any organisation for the submitted work; RB received funding from
Boehringer Ingelheim to present at a symposium; no other relationships or activities that
could appear to have influenced the submitted work.
28 November 2012
Richard Beasley
Professor of Medicine
Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg
Rapid Response:
Re: Call for worldwide withdrawal of tiotropium Respimat mist inhaler
We share the concerns of Duncan Petty and Toby Hillman regarding the illustration of the Handihaler device. The authors did not see or approve the illustration as it was not included in the electronic proofs.
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RB received funding from Boehringer Ingelheim to present at a symposium; no other relationships or activities that could appear to have influenced the submitted work.